CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹4,122 Cr | ₹2,802 Cr | ₹2,517 Cr | ₹2,405 Cr | ₹1,547 Cr |
What is the latest Consolidated Net Profit of CIPLA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹4,122 Cr |
Mar2023 | ₹2,802 Cr |
Mar2022 | ₹2,517 Cr |
Mar2021 | ₹2,405 Cr |
Mar2020 | ₹1,547 Cr |
How is Consolidated Net Profit of CIPLA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹4,122 Cr | 47.10 | |
Mar2023 | ₹2,802 Cr | 11.33 | |
Mar2022 | ₹2,517 Cr | 4.65 | |
Mar2021 | ₹2,405 Cr | 55.50 | |
Mar2020 | ₹1,547 Cr | - |
Compare Consolidated Net Profit of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹122,927.9 Cr | 2.2% | 0.2% | 2.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,824.0 Cr | 0.5% | -0.5% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,355.0 Cr | 1.3% | 10.7% | 49.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,701.0 Cr | 4.7% | 11.9% | 14.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,502.0 Cr | 2% | -0.8% | 15.7% | Stock Analytics | |
MANKIND PHARMA | ₹98,151.0 Cr | 0.7% | -6.7% | 10.3% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 2.2% |
0.2% |
2.3% |
SENSEX | 1.9% |
0.1% |
10.9% |
You may also like the below Video Courses